Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Lags Revenue Estimates

Financial Performance - Establishment Labs Holdings Inc. reported a quarterly loss of $0.98 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.62, and compared to a loss of $0.79 per share a year ago, indicating a significant earnings surprise of -58.06% [1] - The company posted revenues of $44.51 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 0.64%, but showing an increase from year-ago revenues of $31.56 million [2] - The current consensus EPS estimate for the upcoming quarter is -$0.54 on revenues of $43.43 million, and for the current fiscal year, it is -$1.83 on revenues of $207.11 million [7] Market Performance - Establishment Labs shares have declined approximately 22.3% since the beginning of the year, contrasting with the S&P 500's gain of 1.3% [3] - The company has surpassed consensus EPS estimates two times over the last four quarters, while also topping consensus revenue estimates two times in the same period [2] Industry Outlook - The Medical Services industry, to which Establishment Labs belongs, is currently ranked in the top 32% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% of industries [8] - The earnings outlook and estimate revisions trend for Establishment Labs is currently unfavorable, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expectations of underperformance in the near future [6]